Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Polycythemia Vera 4 Lung Neoplasms 4 Myeloproliferative Disorders 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Thymic aplasia 1 Thrombosis 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Sarcoma 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1

Interventions

Everolimus 8 Sunitinib 7 Temozolomide 5 Octreotide 4 Fluorouracil 4 lutetium Lu 177 dotatate 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Capecitabine 3 cabozantinib 2 Thalidomide 2 Streptozocin 2 Oxaliplatin 2 Irinotecan 2 Injections 2 Endoscopic Ultrasound-Guided Fine Needle Aspiration 2 Doxorubicin 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 surufatinib 1 sargramostim 1 sapanisertib 1 recombinant interferon alpha 2b-like protein 1 pasireotide 1 napabucasin 1 motesanib diphosphate 1 montanide ISA 51 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03741517 2022-05-18

Biomarker Study of Pancreatic Neuroendocrine Tumours

Uppsala University

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡